Prediction of Adverse Events during Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes

Intensive chemotherapy for newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) is associated with significant treatment-related morbidity and mortality. Herein, we investigate how pre-treatment characteristics relate to early adverse outcomes in such patients. Among 205 c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Hematol
Main Authors: Buckley, Sarah A., Othus, Megan, Vainstein, Vladimir, Abkowitz, Janis L., Estey, Elihu H., Walter, Roland B.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4391649/
https://ncbi.nlm.nih.gov/pubmed/24382796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23661
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares